Title |
Mushroom Ganoderma lucidum Prevents Colitis-Associated Carcinogenesis in Mice
|
---|---|
Published in |
PLOS ONE, October 2012
|
DOI | 10.1371/journal.pone.0047873 |
Pubmed ID | |
Authors |
Daniel Sliva, Jagadish Loganathan, Jiahua Jiang, Andrej Jedinak, John G. Lamb, Colin Terry, Lee Ann Baldridge, Jiri Adamec, George E. Sandusky, Shailesh Dudhgaonkar |
Abstract |
Epidemiological studies suggest that mushroom intake is inversely correlated with gastric, gastrointestinal and breast cancers. We have recently demonstrated anticancer and anti-inflammatory activity of triterpene extract isolated from mushroom Ganoderma lucidum (GLT). The aim of the present study was to evaluate whether GLT prevents colitis-associated carcinogenesis in mice. |
X Demographics
The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 2 | 22% |
Turkey | 2 | 22% |
Mexico | 1 | 11% |
Unknown | 4 | 44% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 7 | 78% |
Practitioners (doctors, other healthcare professionals) | 2 | 22% |
Mendeley readers
The data shown below were compiled from readership statistics for 69 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 1 | 1% |
United States | 1 | 1% |
Unknown | 67 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 10 | 14% |
Student > Ph. D. Student | 9 | 13% |
Researcher | 7 | 10% |
Student > Bachelor | 6 | 9% |
Student > Postgraduate | 5 | 7% |
Other | 14 | 20% |
Unknown | 18 | 26% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 16 | 23% |
Biochemistry, Genetics and Molecular Biology | 9 | 13% |
Medicine and Dentistry | 6 | 9% |
Nursing and Health Professions | 4 | 6% |
Engineering | 3 | 4% |
Other | 7 | 10% |
Unknown | 24 | 35% |